New 'Touch' test could spot breast cancer faster than biopsy

NCT ID NCT06085833

Recruiting now Diagnosis Sponsor: ARTIDIS AG Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new device called ARTIDIS that measures how stiff or soft breast tissue is, which may help doctors tell if a lump is cancerous. About 2,700 people with suspicious breast lesions will have their biopsy tissue tested with this device. The goal is to see if it can accurately diagnose cancer and predict how aggressive it is, compared to standard lab analysis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ARTIDIS ART-1 device (nanomechanical phenotype test)
What this could lead to: If successful, this could provide a faster, more accurate way to diagnose breast cancer and predict tumor aggressiveness without relying solely on traditional pathology.
What could go wrong: This is an early-stage diagnostic study, not a treatment trial. The device's accuracy may not be high enough to replace current methods, and results may vary across different patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Baylor College of Medicine
RECRUITING

Houston, Texas, 77030, United States
Claraspital
RECRUITING

Basel, Basel, CH-4058, Switzerland
Hospital Universitario Vall d'Hebron
RECRUITING

Barcelona, Barcelona, 08035, Spain
MD Anderson Cancer Clinic - Mays Clinic
RECRUITING

Houston, Texas, 77030, United States
University of Texas Southwestern Medical Center
RECRUITING

Dallas, Texas, 75390-9020, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.